Zobrazeno 1 - 3
of 3
pro vyhledávání: ''
Autor:
Sibylle Koletzko, Lissy de Ridder, Gábor Veres, Johanna C. Escher, Zrinjka Mišak, Jorge Amil Dias, Sanja Kolaček, Gigi Veereman-Wauters, Jean-François Rahier, John Fell, Petter Malmborg
Publikováno v:
Journal of Pediatric Gastroenterology and Nutrition, 54(6), 830-837. Lippincott Williams & Wilkins
Combined immunosuppression by immunomodulators and biological therapy has become standard in the medical management of moderate-to-severe inflammatory bowel disease (IBD) because of clearly demonstrated efficacy. Clinical studies, registries, and cas
Publikováno v:
Journal of Pediatric Gastroenterology and Nutrition, 36, 464-469. Lippincott Williams & Wilkins
Objectives: Treatment options for patients with Crohn disease (CD) have expanded, but the use of some of these options in pediatric patients remains controversial. The authors evaluate current trends in treatment and areas of consensus or controversy
Autor:
Cristina Saro, Ana Gutiérrez, José Luis Cabriada, E. Domènech, Valle Garcia, Joaquín Hinojosa, Xavier Aldeguer, Isabel Vera, Esther Garcia-Planella, Mireia Peñalva, Pere Vilar, Pilar Nos, Juan Luis Mendoza, Miguel Montoro, Javier P. Gisbert, Montserrat Andreu, Jesus Barrio, María Chaparro, Julián Panés, Olga Merino, Maria Esteve, M Barreiro-de, Fernando Muñoz
Publikováno v:
INFLAMMATORY BOWEL DISEASES
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Background: Adalimumab is an effective treatment for Crohn's disease (CD), but may also be associated with loss of response. Few reports provide insight into the durability of treatment of CD with adalimumab for periods longer than 12 months in clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03115f98d9e6289da2a5129e7b4ee860
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1594
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1594